hesperidin has been researched along with Cancer of Pancreas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, DH; Kim, JH; Lee, J | 1 |
| Namiki, M; Obara, T; Okamura, K; Ura, H | 1 |
2 other study(ies) available for hesperidin and Cancer of Pancreas
| Article | Year |
|---|---|
Combined administration of naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancreatic cancer via down regulation of FAK and p38 signaling pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Citrus; Down-Regulation; Flavanones; Focal Adhesion Kinase 1; Hesperidin; Humans; MAP Kinase Signaling System; Mice, Inbred BALB C; Pancreatic Neoplasms; Phosphorylation; Xenograft Model Antitumor Assays | 2019 |
[Growth inhibition of pancreatic cancer cells by flavonoids].
Topics: Cell Cycle; Cell Division; Depression, Chemical; Flavonoids; Genistein; Growth Inhibitors; Hesperidin; Humans; Isoflavones; Luteolin; Pancreatic Neoplasms; Quercetin; Rutin; Tumor Cells, Cultured | 1993 |